arrow
Return

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts

delete2025-09-25
delete0
PRE
AI
A
Ashwini Uchil
L
Louis Lacombe
H
Hélène Hovington
H
Hervé Brisson
D
David Simonyan
P
Patrick Caron
V
Véronique Ouellet
M
Mathieu Latour
A
Armen Aprikian
A
Alain Bergeron
S
Simone Chevalier
G
Ginette McKercher
F
Fadi Brimo
L
Ladan Fazli
N
Neil Fleshner
M
Martin Gleave
P
Pierre I. Karakiewicz
M
Michel Carmel
Z
Zineb Hamilou
D
Dominique Trudel
T
Theodorus van der Kwast
A
Anne‐Marie Mes‐Masson
X
Xuesen Dong
F
Fred Saad
C
Chantal Guillemette
É
Éric Lévesque *
DOI:10.1016/j.euo.2025.07.014delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Prostate cancer (PCa) is hormone dependent, with UDP-glucuronosyltransferase 2B17 (UGT2B17) playing a central role in androgen inactivation. This study aimed to evaluate whether UGT2B17 expression in prostatectomy specimens can serve as a prognostic marker for lethal PCa.

Journal

European Urology Oncology cover
European Urology Oncology
IF:
9.3
Papers:
1.3K
Citations:
4.1K

Organization

C
crchuqc-ul
Scholars:
1
Papers: 1
Citations: 0
U
Université de Sherbrooke
Scholars:
584
Papers: 257
Citations: 9.9K
V
vancouver prostate cancer centre
Scholars:
3
Papers: 1
Citations: 0
I
institut du cancer de montréal
Scholars:
7
Papers: 1
Citations: 0
M
McGill University
Scholars:
5.5W
Papers: 4.9W
Citations: 7.0W
U
university health network
Scholars:
2.4K
Papers: 822
Citations: 5
U
Université Laval
Scholars:
1.5K
Papers: 643
Citations: 0
researcher View more organizations